Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation — an update from the EU Early Warning System, June 2018

This is the second update from the EU Early Warning System. In these publications, the EMCDDA aims to
provide some insights into what is happening with new psychoactive substances in Europe, based on data from
the agency’s early warning and risk assessment activities. This issue covers the period from January 2016 until
December 2017, with aggregated data on seizures reported by law enforcement limited to 2016 data. A focus of this publication is the new fentanils (which form the large majority of the new synthetic opioids that have been
reported in Europe) and the synthetic cannabinoids.